Position in BNTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,450,510
+$98,594 QoQ
Shares Held
27,571
+11.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Derivatives in BNTX
reported options exposure · as of Sep 30, 2021CallValue
$65,544,899
CallShares
240,100
PutValue
$69,448,656
PutShares
254,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026IMC-Chicago, LLC holds $52,313,144 across 39 Biotechnology names. BNTX ranks #4 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
563,670 | $13,956,469 | |
| 2 | ABVX |
Abivax S.A.
|
106,143 | $11,819,023 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
7,795 | $4,080,448 | |
| 4 | BNTX |
BioNTech SE
This page
|
27,571 | $2,450,510 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
59,232 | $2,382,903 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,533 | $2,024,165 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
7,847 | $1,326,299 | |
| 8 | ARGX |
Argenx SE
|
1,747 | $1,275,746 |
All Filings in BNTX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,450,510 | 27,571 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,351,916 | 24,705 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,716,579 | 17,406 | Shares | Sole | 2025-11-04 | |
| 2025-03-31 | $2,869,118 | 31,508 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,515,990 | 13,304 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,852,423 | 32,436 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $2,905,335 | 36,154 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $2,401,267 | 26,030 | Shares | Sole | 2024-04-12 | |
| 2022-06-30 | $3,930,872 | 26,364 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,388,522 | 14,004 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $3,977,080 | 15,427 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $65,544,899 | 240,100 | Call | Sole | 2021-11-05 | |
| 2021-09-30 | $69,448,656 | 254,400 | Put | Sole | 2021-11-05 | |
| 2021-09-30 | $7,349,436 | 26,922 | Shares | Sole | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||